JP2022018946A - Method for producing regenerated human skin tissue - Google Patents

Method for producing regenerated human skin tissue Download PDF

Info

Publication number
JP2022018946A
JP2022018946A JP2020122407A JP2020122407A JP2022018946A JP 2022018946 A JP2022018946 A JP 2022018946A JP 2020122407 A JP2020122407 A JP 2020122407A JP 2020122407 A JP2020122407 A JP 2020122407A JP 2022018946 A JP2022018946 A JP 2022018946A
Authority
JP
Japan
Prior art keywords
human
adipose tissue
stem cells
cells
fibroblasts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020122407A
Other languages
Japanese (ja)
Inventor
志斈 池田
Shigaku Ikeda
有里 池田
Yuuri Ikeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Juntendo University
Original Assignee
Juntendo University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Juntendo University filed Critical Juntendo University
Priority to JP2020122407A priority Critical patent/JP2022018946A/en
Publication of JP2022018946A publication Critical patent/JP2022018946A/en
Pending legal-status Critical Current

Links

Images

Abstract

To provide a method for producing regenerated skin tissue including keratinocytes, melanocytes and fibroblasts.SOLUTION: In a method for producing regenerated human skin tissue including human mature melanocytes, human keratinocytes and human fibroblasts, human adipose tissue stem cells including human melanocyte progenitor cells are cultured with human fibroblasts and human keratinocytes.SELECTED DRAWING: None

Description

本発明は、再生ヒト皮膚組織の製造法に関する。 The present invention relates to a method for producing regenerated human skin tissue.

重症熱傷、皮膚潰瘍、分節型尋常性白斑等の皮膚疾患に対する治療手段として、自家及び他家(同種)培養皮膚、色素細胞の移植が行なわれている。また、ES細胞、iPS細胞(非特許文献1)、間葉系幹細胞(非特許文献2、3)、Muse細胞(非特許文献4、5)等を皮膚の再生医療に用いる試みもなされつつある。 As a therapeutic means for skin diseases such as severe burns, skin ulcers, and segmental vitiligo vulgaris, autologous and allogeneic (homogeneous) cultured skin and pigment cell transplantation are performed. Attempts are also being made to use ES cells, iPS cells (Non-Patent Document 1), mesenchymal stem cells (Non-Patent Documents 2 and 3), Muse cells (Non-Patent Documents 4 and 5) and the like for skin regenerative medicine. ..

PLoS One, 2012:7(12):e52787PLoS One, 2012: 7 (12): e52787 Am. J. Pathol. 173:803-814,2008Am. J. Pathol. 173: 803-814,2008 Immunotherapy 4:1859-1867, 2012Immunotherapy 4: 1859-1867, 2012 Proc. Natl. Acad. Sci. USA 107:8639-8643, 2010Proc. Natl. Acad. Sci. USA 107: 8639-8643, 2010 Proc. Natl. Acad. Sci. USA 108:9875-9880, 2011Proc. Natl. Acad. Sci. USA 108: 9875-9880, 2011

しかし、ES細胞やiPS細胞の表皮角化細胞への分化は誘導率が低く、また、腫瘍形成の可能性の問題がある。骨髄間葉系細胞は採取が容易でない等の問題がある。
従って、容易に入手可能な細胞を用いた再生皮膚組織の製造法の開発が望まれており、本発明はケラチノサイト、メラノサイト及び線維芽細胞を含む再生皮膚組織の製造法を提供することにある。
However, the differentiation of ES cells and iPS cells into epidermal keratinocytes has a low induction rate, and there is a problem of the possibility of tumor formation. Bone marrow mesenchymal cells have problems such as not being easy to collect.
Therefore, it is desired to develop a method for producing a regenerated skin tissue using readily available cells, and the present invention provides a method for producing a regenerated skin tissue containing keratinocytes, melanocytes and fibroblasts.

そこで本発明者は、容易に採取が可能な皮下脂肪組織に着目して検討してきたところ、全く意外にも、脂肪組織幹細胞中にメラノサイト前駆細胞が分化誘導をかける前に既に存在していることを見出した。そして、そのメラノサイト前駆細胞はメラノサイト特異的培地で培養すれば、メラノサイト特異的マーカー蛋白を明確に発現するようになることも見出した。さらに、これらのメラノサイト前駆細胞を、ヒト線維芽細胞及びヒトケラチノサイトと共に培養すれば、ヒト成熟メラノサイト、ヒトケラチノサイト及びヒト線維芽細胞を含有する再生ヒト皮膚組織が得られることを見出し、本発明を完成した。 Therefore, the present inventor has focused on subcutaneous adipose tissue that can be easily collected, and found that, surprisingly, melanosite progenitor cells already exist in adipose tissue stem cells before inducing differentiation. I found. They also found that the melanocyte progenitor cells clearly express the melanocyte-specific marker protein when cultured in a melanocyte-specific medium. Furthermore, they have found that if these melanocyte progenitor cells are cultured together with human fibroblasts and human keratinocytes, regenerated human skin tissue containing human mature melanocytes, human keratinocytes and human fibroblasts can be obtained, and the present invention has been completed. did.

すなわち、本発明は、次の[1]~[3]を提供するものである。
[1]ヒトメラノサイト前駆細胞を含有するヒト脂肪組織幹細胞を、ヒト線維芽細胞及びヒトケラチノサイトと共に培養することを特徴とする、ヒト成熟メラノサイト、ヒトケラチノサイト及びヒト線維芽細胞を含有する再生ヒト皮膚組織の製造法。
[2]ヒトメラノサイト前駆細胞を含有するヒト脂肪組織幹細胞が、ヒトメラノサイト前駆細胞を含有するヒト脂肪組織幹細胞、又はヒトメラノサイト前駆細胞を含有するヒト脂肪組織幹細胞をメラノサイト特異的培地で培養した細胞である[1]記載の再生ヒト皮膚組織の製造法。
[3]前記ヒト線維芽細胞及びヒトケラチノサイトと共に行う培養系が、コラーゲンゲル中で、ヒト線維芽細胞、ヒトケラチノサイト及び前記ヒト脂肪組織幹細胞を培養する系である[1]又は[2]記載の再生ヒト皮膚組織の製造法。
That is, the present invention provides the following [1] to [3].
[1] Regenerated human skin tissue containing human mature melanocytes, human keratinocytes and human fibroblasts, which comprises culturing human adipose tissue stem cells containing human melanosite progenitor cells together with human fibroblasts and human keratinocytes. Manufacturing method.
[2] Human adipose tissue stem cells containing human melanosite progenitor cells are human adipose tissue stem cells containing human melanosite progenitor cells or cells obtained by culturing human adipose tissue stem cells containing human melanosite progenitor cells in a melanosite-specific medium. [1] The method for producing a regenerated human skin tissue according to [1].
[3] The system according to [1] or [2], wherein the culture system performed together with the human fibroblasts and human keratinocytes is a system for culturing human fibroblasts, human keratinocytes and the human adipose tissue stem cells in a collagen gel. A method for producing regenerated human skin tissue.

本発明で用いる脂肪組織由来幹細胞は、脂肪組織1gから約5×103個と骨髄組織由来幹細胞に比べて500倍多く採取可能であり、入手が容易である。また、脂肪組織由来幹細胞は抗原性が低く、免疫抑制作用を有することから、これらから分化誘導されるヒト成熟メラノサイトも抗原性が低く、皮膚に移植が可能である。また、本発明で得られる再生皮膚組織は、ヒトケラチノサイト、ヒト成熟メラノサイトだけでなく線維芽細胞も有し、皮膚の表皮から基底層及び真皮までの機能を有するため、種々の皮膚疾患や老化皮膚への対処が可能である。 The adipose tissue-derived stem cells used in the present invention can be collected from 1 g of adipose tissue to about 5 × 10 3 cells, which is 500 times as much as that of bone marrow tissue-derived stem cells, and are easily available. In addition, since adipose tissue-derived stem cells have low antigenicity and have an immunosuppressive effect, human mature melanocytes induced to differentiate from them also have low antigenicity and can be transplanted into the skin. In addition, the regenerated skin tissue obtained by the present invention has not only human keratinocytes and human mature melanocytes but also fibroblasts and has functions from the epidermis to the basal layer and dermis of the skin, so that various skin diseases and aged skin are present. Can be dealt with.

脂肪組織幹細胞の免疫染色結果を示す。The results of immunostaining of adipose tissue stem cells are shown. 脂肪組織幹細胞の免疫染色結果を示す。The results of immunostaining of adipose tissue stem cells are shown. 脂肪組織幹細胞のRT-PCR結果を示す。The RT-PCR results of adipose tissue stem cells are shown. 脂肪組織幹細胞のRT-PCR結果を示す。The RT-PCR results of adipose tissue stem cells are shown. siRNA法で脂肪組織幹細胞のHMB45をノックダウンした結果を示す。The results of knocking down HMB45 of adipose tissue stem cells by the siRNA method are shown. 脂肪組織幹細胞のウェスタンブロッティングの結果を示す。The results of Western blotting of adipose tissue stem cells are shown. 脂肪組織幹細胞のウェスタンブロッティングの結果を示す。The results of Western blotting of adipose tissue stem cells are shown. 脂肪組織幹細胞の免疫電顕の結果を示す。The results of immunoelectron microscopy of adipose tissue stem cells are shown. 3次元培養後の組織のHMB45とチロシナーゼ(TYR)の発現を示す。The expression of HMB45 and tyrosinase (TYR) in the tissue after 3D culture is shown.

本発明は、ヒトメラノサイト前駆細胞を含有するヒト脂肪組織幹細胞を、ヒト線維芽細胞及びヒトケラチノサイトと共に培養することを特徴とする、ヒト成熟メラノサイト、ヒトケラチノサイト及びヒト線維芽細胞を含有する再生ヒト皮膚組織の製造法である。 The present invention comprises culturing human adipose tissue stem cells containing human melanocyte progenitor cells together with human fibroblasts and human keratinocytes, the regenerated human skin containing human mature melanocytes, human keratinocytes and human fibroblasts. It is a method of manufacturing a tissue.

本発明の製造法の原料は、ヒトメラノサイト前駆細胞を含有するヒト脂肪組織幹細胞である。
原料である脂肪組織幹細胞は、脂肪組織、例えば皮下脂肪組織をコラゲナーゼ処理後、遠心分離により間質血管細胞群を分離することにより採取することができる。
得られた脂肪組織幹細胞であることは、(1)この細胞が、CD34、CD44、CD90及びCD105陽性であること、(2)この細胞を、3-イソブチル-1-メチルキサンチン、ビオチン、パントテン酸塩、ロシグリタゾン、デキサメサゾン、インスリン等の存在下に培養して脂肪細胞へ分化すること、を確認すればよい。
脂肪組織幹細胞は、患者に対して拒絶反応を生じないヒトを含む動物由来であればよいが、自家細胞が望ましい。
The raw material of the production method of the present invention is human adipose tissue stem cells containing human melanocyte progenitor cells.
Adipose tissue stem cells, which are raw materials, can be collected by treating adipose tissue, for example, subcutaneous adipose tissue with collagenase and then centrifuging to separate stromal vascular cells.
The obtained adipose tissue stem cells are (1) that the cells are CD34, CD44, CD90 and CD105 positive, and (2) that the cells are 3-isobutyl-1-methylxanthine, biotin, pantothenic acid. It may be confirmed that the cells are cultured in the presence of salt, rosiglitazone, dexamesazone, insulin and the like to differentiate into adipocytes.
The adipose tissue stem cells may be derived from animals including humans that do not cause rejection to the patient, but autologous cells are preferable.

本発明者は、採取が容易な皮下脂肪組織から分離したヒト脂肪組織幹細胞中に、ヒトメラノサイト前駆細胞が存在することを初めて見出した。すなわち、後記実施例に示すように、a)免疫染色により、メラノサイトのマーカータンパクである、MelanA、MATP、HMB45(前駆メラノソームタンパク)、LAMP1、MITF、TYR、MelEM、Mel2が分化誘導前のヒト脂肪組織幹細胞で発現しており、b)RT-PCRで、分化誘導前のヒト脂肪組織幹細胞でMITF、KIT、PAX3のメラノサイトの転写因子が発現しており、c)siRNA法でヒト脂肪組織幹細胞のHMB45をノックダウンすると、この細胞おけるHMB45の発現が消褪し、d)ウェスタンブロッティングにおいて、分化誘導前のヒト脂肪組織幹細胞でHMB45とMITFが発現しており、e)免疫電顕でも、分化誘導前の脂肪細胞幹細胞でHMB45が発現していることを確認した。
本発明では、このようにヒトメラノサイト前駆細胞を含有するヒト脂肪組織幹細胞を使用することができる。
The present inventor has found for the first time that human melanocyte progenitor cells are present in human adipose tissue stem cells isolated from easy-to-collect subcutaneous adipose tissue. That is, as shown in Examples below, a) by immunostaining, the melanosite marker proteins MelanA, MATP, HMB45 (precursor melanosomes protein), LAMP1, MITF, TYR, MelEM, and Mel2 are human fats before induction of differentiation. It is expressed in tissue stem cells, b) RT-PCR shows that melanosite transcription factors of MITF, KIT, and PAX3 are expressed in human adipose tissue stem cells before induction of differentiation, and c) human adipose tissue stem cells are expressed by the siRNA method. When HMB45 is knocked down, the expression of HMB45 in these cells disappears, and d) HMB45 and MITF are expressed in human adipose tissue stem cells before induction of differentiation in western blotting, and e) induction of differentiation by immunoelectron microscopy. It was confirmed that HMB45 was expressed in the previous fat cell stem cells.
In the present invention, human adipose tissue stem cells thus containing human melanocyte progenitor cells can be used.

また、ヒトメラノサイト前駆細胞を含有するヒト脂肪組織幹細胞は、メラノサイト特異的培地で培養すると、メラノサイトマーカータンパクの発現がさらに増強するので、本発明においては、このヒトメラノサイト前駆細胞を含有するヒト脂肪組織幹細胞をメラノサイト特異的培地で培養したヒト脂肪組織幹細胞を用いるのがより好ましい。ここで、メラノサイトマーカータンパクの発現増強は、前記免疫染色、RT-PCR、siRNA法によるHMB45ノックダウン、ウェスタンブロッティング、免疫電顕により確認することができる。
メラノサイト特異的培地としては、例えば、基礎培地としてKURABO社のDermaLife(登録商標)BM(KURABO)にDermaLife(登録商標)M LifeFactors(L-グルタミン15mL、エピネフリン0.5mL、インスリン0.5mL、StiMel8(登録商標)LifeFactor5mL、アスコルビン酸0.5mL、塩化カルシウム1.0mL、ゲンタマイシン/アンフォテリシン0.5mL)を添加したものを使用できる。
その他に上記培地にさらにWnt3a(R&Dsystems(登録商標))50ng/ml、Endothelin3(SIGMA-ALDRICH)100nM、SCF(R&Dsystems(登録商標)10ng/mL、cholera toxin(FUJIFILM)1.66mg/L、Linoleic acid(Nacalai)25μM in ethanolを添加した培地も使用できる。
Further, when human adipose tissue stem cells containing human melanosite progenitor cells are cultured in a melanosite-specific medium, the expression of melanosite marker protein is further enhanced. Therefore, in the present invention, human adipose tissue containing the human melanosite progenitor cells. It is more preferable to use human adipose tissue stem cells obtained by culturing stem cells in a melanosite-specific medium. Here, the enhanced expression of the melanocyte marker protein can be confirmed by the immunostaining, RT-PCR, HMB45 knockdown by the siRNA method, Western blotting, and immunoelectron microscopy.
Examples of the melanosite-specific medium include DermaLife (registered trademark) BM (KURABO) of KURABO, and DermaLife (registered trademark) M LifeFactors (L-glutamine 15 mL, epinephrine 0.5 mL, insulin 0.5 mL, StiMel8) as a basal medium. Registered trademark) LifeFactor 5 mL, ascorbic acid 0.5 mL, calcium chloride 1.0 mL, gentamicin / amphotericin 0.5 mL) can be used.
In addition, Wnt3a (R & Dsystems®) 50 ng / ml, Ethanol3 (SIGMA-ALDRICH) 100 nM, SCF (R & Dsystems® 10 ng / mL, cholera toxin (FUJIFILM) 1.66 mg / L A medium supplemented with (Nacalai) 25 μM in ethanol can also be used.

ヒト脂肪組織幹細胞をメラノサイト特異的培地で培養するには、例えば、コラーゲンIV(5μg/mL 新田ゼラチン)コートしたシャーレにヒト脂肪組織幹細胞を播種しヒト脂肪組織幹細胞専用培地(ADSC-BM, LONZA)を用いて3~7日程度培養を行うのが好ましい。その後メラノサイト特異的培地に培地交換を行い、7~14日程度培養を行うのが好ましい。 To culture human adipose tissue stem cells in a melanosite-specific medium, for example, seed human adipose tissue stem cells in a petri dish coated with collagen IV (5 μg / mL Nitta gelatin) and use a medium for human adipose tissue stem cells (ADSC-BM, LONZA). ) Is preferably used for culturing for about 3 to 7 days. After that, it is preferable to replace the medium with a melanocyte-specific medium and culture for about 7 to 14 days.

ヒトメラノサイト前駆細胞を含有するヒト脂肪組織幹細胞を、ヒト線維芽細胞及びヒトケラチノサイトと共に培養する。
ヒト線維芽細胞としては、ヒト真皮線維芽細胞が好ましい。
線維芽細胞は、結合組織から採取することができ、例えば、皮膚を径5mm大で切り取り、その真皮成分より採取することができる。
ヒトケラチノサイトとしては、例えば、KURABO社の凍結NHEKを使用することができる。
Human adipose tissue stem cells containing human melanocyte progenitor cells are cultured with human fibroblasts and human keratinocytes.
As the human fibroblast, human dermal fibroblast is preferable.
Fibroblasts can be collected from connective tissue, for example, the skin can be cut to a diameter of 5 mm and collected from the dermis component thereof.
As the human keratinocyte, for example, frozen NHEK manufactured by KURABO can be used.

これらの細胞の共培養手段としては、3次元培養法が好ましく、皮膚組織を再生する点から、コラーゲンゲル中で、ヒト線維芽細胞、ヒトケラチノサイト及び前記ヒト脂肪組織幹細胞を培養する系であるのがより好ましい。さらには、皮膚組織においては、線維芽細胞を含有する真皮の上層に基底層を介してメラノサイト及びケラチノサイトを含有する表皮が存在することから、コラーゲンゲル中に線維芽細胞を包埋培養したヒトケラチノサイトと前記ヒト脂肪組織幹細胞を重ねて培養する3次元培養系が好ましい。ここで、コラーゲンゲルは、I型及びIV型コラーゲンゲルであるのが好ましい。
3次元培養法の培養条件は、まず6wellプレート(IWAKI)とTrans wellのコラーゲンIVコート(5μg/mL)を行う。Trans well上に線維芽細胞を5.0x10~1.0x10cells/wellでコラーゲンIゲルに包埋し播種し2日程度培養する。2日経過後、その上にメラノサイトに誘導したヒト脂肪組織由来幹細胞を2.5x10~5.0x10cells/wellで播種する。さらにその上にNHEKを5.0x10~1.0x10cells/wellで播種し、その後14~15日程度培養する。培地は6wellのlowerはNHDF Mediumとして10%FBS入りDMEM High Glucose(nacalai tesque)を使用(2ml/well)。Trans well upperには、上記のメラノサイト特異的培地を500μLとNHEK MediumとしてHuMedia-KG2(インスリン、hEGF、ハイドロコーチゾン、BPEを添加;kurabo)500μLを添加する。2日に一回程度培地交換を施行するのが好ましい。
As a means for co-culturing these cells, a three-dimensional culture method is preferable, and from the viewpoint of regenerating skin tissue, it is a system for culturing human fibroblasts, human keratinocytes and the human adipose tissue stem cells in collagen gel. Is more preferable. Furthermore, in the skin tissue, since the epidermis containing melanocytes and keratinocytes is present in the upper layer of the dermis containing fibroblasts via the basal layer, human keratinocytes in which fibroblasts are embedded and cultured in collagen gel. A three-dimensional culture system in which the human adipose tissue stem cells are superposed and cultured is preferable. Here, the collagen gel is preferably type I or type IV collagen gel.
As the culture conditions of the three-dimensional culture method, first, a 6-well plate (IWAKI) and a collagen IV coat of Trans well (5 μg / mL) are applied. Fibroblasts are embedded in collagen I gel at 5.0x10 4 to 1.0x10 5 cells / well on Trans well, seeded, and cultured for about 2 days. After 2 days, human adipose tissue-derived stem cells induced to melanocytes are seeded on the cells at 2.5x10 4 to 5.0x10 4 cells / well. Further, NHEK is seeded on it at 5.0x10 4 to 1.0x10 5 cells / well, and then cultured for about 14 to 15 days. As the medium, DMEM High Glucose (nacalai tesque) containing 10% FBS was used as the lower of 6 well as NHDF Medium (2 ml / well). To the Trans well upper, 500 μL of the above melanocyte-specific medium and 500 μL of HuMedia-KG2 (insulin, hEGF, hydrocortisone, BPE added; kurabo) as NHEK Medium are added. It is preferable to change the medium about once every two days.

このような3次元培養により、表皮基底層にヒト成熟メラノサイトが誘導され、得られた3次元培養皮膚は、ヒト成熟メラノサイト、ヒトケラチノサイト及びヒト線維芽細胞を含有する再生ヒト皮膚組織である。ここで、ヒトメラノサイト前駆細胞がヒト成熟メラノサイトに分化したことは、チロシナーゼ、すなわちメラニン合成に必須の酵素が発現していることで確認できる。 Human mature melanocytes are induced in the basal layer of the epidermis by such three-dimensional culture, and the obtained three-dimensional cultured skin is a regenerated human skin tissue containing human mature melanocytes, human keratinocytes and human fibroblasts. Here, the differentiation of human melanocyte progenitor cells into human mature melanocytes can be confirmed by the expression of tyrosinase, that is, an enzyme essential for melanin synthesis.

本発明方法によれば、入手が容易なヒト脂肪組織幹細胞を原料として用い、簡便な操作により、ヒト成熟メラノサイト、ヒトケラチノサイト及びヒト線維芽細胞を含有する再生ヒト皮膚組織が得られる。従って、本発明によれば、表皮や毛髪などの再生が可能となる。また、本発明の製造法の過程を検討することにより、皮膚疾患の治療手段や老化皮膚への対処手段の研究が可能となる。 According to the method of the present invention, easily available human adipose tissue stem cells are used as a raw material, and a regenerated human skin tissue containing human mature melanocytes, human keratinocytes and human fibroblasts can be obtained by a simple operation. Therefore, according to the present invention, it is possible to regenerate the epidermis and hair. Further, by examining the process of the manufacturing method of the present invention, it becomes possible to study the means for treating skin diseases and the means for coping with aged skin.

次に実施例を挙げて本発明をさらに詳細に説明するが、本発明はこれら実施例に限定されるものではない。 Next, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples.

[材料及び方法]
(1)ヒト脂肪組織幹細胞の採取
1)皮下脂肪組織を採取し、リン酸緩衝生理食塩水にて洗浄した。コラゲナーゼに浸した後10%仔ウシ血清含有ダルベッコ変法イーグル培地にてコラゲナーゼを中和した。
2)40μmのナイロンメッシュを通して残渣を除去した。1200rpmで10分間遠心し、沈殿物を回収した。再び10%仔ウシ血清含有ダルベッコ変法イーグル培地5mlに溶解し、培養プレートに播種して数日間培養し、培養プレート底面に接着したものが脂肪組織幹細胞である。
3)フローサイトメトリーにてCD34、CD44、CD90、CD105が陽性であることを確認した。
4)得られた細胞を播種して10%仔ウシ血清含有D-MEM/Ham’s F-12培地にて培養後、3%仔ウシ血清及び3-isobutyl-1-methylxanthine、ビオチン、panthothenate、rosiglitazone、デキサメサゾン、ヒトインスリン含有D-MEM/Ham’s F-12培地に変えて3日間培養した。次に前記培地より3-isobutyl-1-methylxanthineを除いたものに変更後、3日ごとに培地を交換し、約12日間培養する。本細胞をOil red O染色にて脂肪細胞に分化していることを確認した。以上の手順3)、4)によって本細胞が脂肪組織幹細胞であることを確認した。
[Materials and methods]
(1) Collection of human adipose tissue stem cells 1) Subcutaneous adipose tissue was collected and washed with phosphate buffered saline. After soaking in collagenase, collagenase was neutralized in Dulbecco's modified Eagle's medium containing 10% calf serum.
2) The residue was removed through a 40 μm nylon mesh. The precipitate was collected by centrifugation at 1200 rpm for 10 minutes. Adipose tissue stem cells are dissolved again in 5 ml of Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, seeded on a culture plate, cultured for several days, and adhered to the bottom surface of the culture plate.
3) It was confirmed by flow cytometry that CD34, CD44, CD90 and CD105 were positive.
4) The obtained cells are seeded and cultured in D-MEM / Ham's F-12 medium containing 10% calf serum, followed by 3% calf serum and 3-isobutyl-1-methylxanthine, biotin, panthenate, The cells were changed to D-MEM / Ham's F-12 medium containing rosiglitazone, dexamesazone, and human insulin, and cultured for 3 days. Next, after changing to the medium from which 3-isobutyl-1-methylxanthine has been removed, the medium is changed every 3 days, and the medium is cultured for about 12 days. It was confirmed that the cells were differentiated into adipocytes by Oil red O staining. It was confirmed by the above steps 3) and 4) that the cells were adipose tissue stem cells.

(2)ヒト線維芽細胞
皮膚を径5mm大で切り取り、その真皮成分より採取することができる。具体的には、線維芽細胞は、同意を得た患者皮膚より採取し培養を行った。
(2) Human fibroblasts The skin can be cut to a diameter of 5 mm and collected from the dermis component thereof. Specifically, fibroblasts were collected from patient skin with consent and cultured.

(3)ヒトケラチノサイト
KURABO社の凍結NHEKを使用した。
(3) Frozen NHEK from KURABO, a human keratinocyte, was used.

(4)免疫染色
HMB45を多重染色、MelanA、MATP、MelEM、MITF、Tyrosinase、Mel2を免疫染色する。
Nunc4wellプレートにカバーガラスをのせ、コラーゲンIVコーティングを施行。その上に誘導したヒト脂肪組織由来幹細胞、ヒト脂肪組織由来幹細胞、メラノーマ細胞を60~70%程度になるまで培養した。
4%パラホルムアルデヒドを用いて常温で15分固定を行う。10%Normal Goat Serumと0.1%サポニン又は0.1%Triton/PBSを用いてブロッキング施行。2%BSA/PBSに0.1%サポニンを加えたもの、または2%BSA/PBS単独に一次抗体としてAnti-HMB45antibody(Abcam ab733 Mouse monoclonak IgG)1/50希釈とAnti-LAMP1antibody-Lysosome Marker(Abcam ab24170 Rabbit polyclonal IgG)1/500希釈を添加する、またはMelEM_DSHB(希釈せずに添加、 Developmental studies hybridoma bank、 host mouse) Anti-MITF antibody (ab20663 Abcam Biotechnology、 host rabbit)1/250, Anti-Melan A antibody (ab210546 Abcam Biotechnology、 host rabbit)1/1000、Mel2 (Anti-Melanocyte cell surface antigen antibody、ab128759、Abcam Biotechnology、 host mouse)1/500、MATP (sc-377397, Abcam Biotechnology, host mouse)1/50, Anti-Tyrosinase antibody(ab738、 Abcam Biotechnology, host mouse)1/250を添加し4℃ overnightで一次抗体反応を行う。
2%BSA/PBSに0.1%サポニンを加えたもの、または2%BSA/PBS単独に二次抗体としてAlexa Fluor 594 donkey anti-mouse IgG(Jackson Immuno Research) 1/300希釈とAlexa Fluor 488 donkey anti-rabbit IgG(Jackson Immuno Research) 1/500希釈を使用、またはAlexa Fluor 488 Goat anti-mouse IgG(Life technologies) 1/400希釈とAlexa Fluor 488 Goat anti-rabbit IgG(Life technologies)) 1/400希釈を使用し室温で1時間二次抗体反応を行う。洗浄後、Mounting Medium with DAPI(Vector Laboratories, Burlingame, CA, USA)を滴下し固定する。
その後キーエンス蛍光顕微鏡(Keyence BZ-X700 fluorescence microscope Osaka)で解析、撮影を行った。
(4) Immunostaining HMB45 is multi-stained, and MelanA, MATP, MelEM, MITF, Tyrosinase, and Mel2 are immunostained.
Place the cover glass on the Nunc4well plate and apply collagen IV coating. The induced human adipose tissue-derived stem cells, human adipose tissue-derived stem cells, and melanoma cells were cultured to about 60 to 70%.
Fix at room temperature for 15 minutes using 4% paraformaldehyde. Blocking was performed using 10% Normal Goat Serum and 0.1% saponin or 0.1% Triton / PBS. 2% BSA / PBS plus 0.1% saponin, or 2% BSA / PBS alone as primary antibody Anti-HMB45 antibody (Abcam ab733 Mouse monoclonak IgG) 1/50 dilution and Anti-LAMP1 antibodyMorsome-Lyso ab24170 Rabbit polyclonal IgG) 1/500 diluted, or MelEM_DSHB (added without dilution, Developmental studios hybridoma bank, host mouse) Anti-MITF antibody 206 antibody (ab210546 Abcam Biotechnology, host rabbit) 1/1000, Mel2 (Anti-Melanocyte cell surface antigen antibody, ab128759, Abcam Biotechnology, host mouse) 1/500, MATP (sc-377397, Abcam Biotechnology, host mouse) 1/50 , Anti-Tyrosinase antibody (ab738, Abcam Biotechnology, host mouse) 1/250 is added and the primary antibody reaction is carried out at 4 ° C. over night.
2% BSA / PBS plus 0.1% saponin, or 2% BSA / PBS alone as a secondary antibody Alexa Fluor 594 donkey antibody-mouse IgG (Jackson Immuno Research) 1/300 dilution and Alexa Fluor 488 donkey Anti-rabbit IgG (Jackson Immuno Research) 1/500 dilution is used, or Alexa Fluor 488 Goat anti-mouse IgG (Life technologies) 1/400 dilution and Alexa Fluor 488 Gite The secondary antibody reaction is carried out at room temperature for 1 hour using dilution. After washing, Mounting Medium with DAPI (Vector Laboratories, Burlingame, CA, USA) is dropped and fixed.
After that, it was analyzed and photographed with a Keyence fluorescence microscope (Keyence BZ-X700 fluororescense microscope Osaka).

(5)RT-PCR
6wellプレート(IWAKI)にコラーゲンIVコートを施行し、誘導したヒト脂肪組織由来幹細胞、ヒト脂肪組織由来幹細胞、陽性コントロールとしてメラノーマ細胞を培養した。
ReverTra Ace qPCR RT kit (Toyobo, Osaka, Japan)を用いて2 μgの RNAを cDNAにする。TaqMan Master Mix (Applied Biosystems, Foster City, CA, USA)を用い1μg cDNAをStep One Plus system (Applied Biosystems)を用いて50サイクルまわす。
内在性コントロールとしてβ-actinを基準とし、HMB45 (Gene Alias: PMEL, Hs00173854_M1), KIT (Hs00174029_M1), MITF (Hs01117294_M1) and PAX3 (Hs00240950_M1) の発現上昇を確認した。
相対的mRNAレベルを算出するのに2-ΔΔCtを使った比較のサイクル閾値(ct)方法を用いた。
(5) RT-PCR
A 6-well plate (IWAKI) was coated with collagen IV, and induced human adipose tissue-derived stem cells, human adipose tissue-derived stem cells, and melanoma cells as positive controls were cultured.
2 μg of RNA is converted to cDNA using the RiverTra Ace qPCR RT kit (Toyobo, Osaka, Japan). Use TaqMan Master Mix (Applied Biosystems, Foster City, CA, USA) to rotate 1 μg cDNA using Step One Plus systems (Applied Biosystems) for 50 cycles.
Based on β-actin as an endogenous control, increased expression of HMB45 (Gene Alias: PMEL, Hs00173854_M1), KIT (Hs00174029_M1), MITF (Hs01117294_M1) and PAX3 (Hs00240950_M1) was confirmed.
A comparative cycle threshold (ct) method using 2-ΔΔCt was used to calculate relative mRNA levels.

(6)siRNA法によるHMB45のノックダウン
誘導したヒト脂肪組織由来幹細胞、ヒト脂肪組織由来幹細胞を6wellプレート(IWAKI)に播種し二日間培養した。
siRNA-1 (siRNA ID♯:S12861,sense: 5‘-GGUUAUCUGGGUCAACAAUtt-3’(配列番号1) and antisense: 3‘-AUUGUUGACCCAGAUAACCtg-5’(配列番号2)), siRNA-2 (siRNA ID♯:S12859, sense: 5‘-AGAAGUUGUGGGUACUACAtt-3’(配列番号3) and antisense: 3‘-UGUAGUACCCACAACUUCUgt-5’(配列番号4)), siRNA-3 (siRNA ID♯:S12860, sense: 5‘-UAUCAUGCCUGGUCAAGAAtt-3’(配列番号5) and antisense: 3‘-UUCUUGACCAGGCAUGAUAag-5’(配列番号6))の3つのHMB45を対象としたsiRNAをSilencer select siRNA (Thermo Fisher Scientific, USA)によりデザインした。
OptiMem と Lipofectamine RNAi MAX Reagent (Themo Fisher Scientific, USA)を用いて30pmol SiRNA1.2.3をsiRNA-Negative control (Silencer Select ♯4390843), siRNA-Positive control GAPDH (Silencer Select ♯4390849)とともに遺伝子導入した。
48時間後にリアルタイムPCRでHMB45の発現が抑制されていることを確認した。
(6) Human adipose tissue-derived stem cells and human adipose tissue-derived stem cells in which HMB45 was knocked down by the siRNA method were seeded on a 6-well plate (IWAKI) and cultured for 2 days.
siRNA-1 (siRNA ID #: S12861, sense: 5'-GGUUAUCUGGUCAACAAUTt-3'(SEQ ID NO: 1) and antisense: 3'-AUUGUGACCAGAUACCtg-5'(SEQ ID NO: 2)), siRNA-2 , sense: 5'-AGAAGUGUGGUACUACatt-3'(SEQ ID NO: 3) and antisense: 3'-UGUAGUACCCACAACUUCUgt-5' (SEQ ID NO: 4)), siRNA-3 (siRNA ID #: S12860, sen '(SEQ ID NO: 5) and antisense: 3'-UCUUGACAGGCAUGAUAag-5'(SEQ ID NO: 6)) 3 HMB45 siRNAs designed by Silcer select siRNA (Thermo Fisher Scientific, USA).
OptiMem and Lipofectamine RNAi MAX Reagent (Themo Fisher Scientific, USA) were used to introduce 30 pmol SiRNA 1.2.3 with siRNA-Negative control.
After 48 hours, it was confirmed by real-time PCR that the expression of HMB45 was suppressed.

(7)ウェスタンブロッティング
6wellプレート(IWAKI)にコラーゲンIVコートを施行し、誘導したヒト脂肪組織由来幹細胞、ヒト脂肪組織由来幹細胞、陽性コントロールとしてメラノサイトを培養した。
M-PER Mammalian Protein Extraction Reagent と1/100希釈したProtease inhibitor cocktail (P8340,Sigma-Aldrich)を用いて細胞の蛋白回収を行う。
10% Tris-glycine SDS-PAGE (Bio-Rad, Hercules, CA, USA)を用いて電気泳動を行い、ニトロセルロースメンブレンに転写する。
Tris-buffered salineに5%スキムミルクを溶かし、ブロッキングを施行。抗HMB45抗体(1:100; from Santa Cruz Biotechnology)と抗MITF抗体(1μg/mL; from Abcam Biotechnology) β-actin monoclonal antibody (1:2000; BioLegend, San Diego, CA, USA)に浸し、4℃ overnightで一次抗体反応を行う。洗浄後、anti-mouse peroxidase-conjugated secondary antibody (1:2000, Cell Signaling Technology, USA)とanti-rabbit antibody (1:2000, Cell Signaling Technology, USA)を用いて二次抗体反応を一時間室温で行う。SuperSignal West Dura Extended Duration Substrate (Thermo-Scientific,USA)で標識しImageQuant LAS 4000 system (Cytiva, Tokyo, Japan)で解析を行った。
(7) Western blotting A collagen IV coat was applied to a 6-well plate (IWAKI), and induced human adipose tissue-derived stem cells, human adipose tissue-derived stem cells, and melanosite as a positive control were cultured.
Cellular protein recovery is performed using M-PER Mammalian Protein Extension Reagent and 1/100 diluted Protease inhibitor cocktail (P8340, Sigma-Aldrich).
Electrophoresis is performed using 10% Tris-glycine SDS-PAGE (Bio-Rad, Hercules, CA, USA) and transferred to a nitrocellulose membrane.
Dissolve 5% skim milk in Tris-buffered saline and perform blocking. Anti-HMB45 antibody (1: 100; from Santa Cruz Biotechnology) and anti-MITF antibody (1 μg / mL; from Abcam Biotechnology) β-actin monoclonal antibody, Body (1: 2000; Perform the primary antibody reaction overnight. After washing, anti-mouse peroxidase-conjugated secondary antibody (1: 2000, Cell Signaling Technology, USA) and anti-rabbit antibody (USA) and anti-rabbit antibody (1: 2000, Cell Signaling) with antibody at room temperature (1: 2000, Cell Signaling) conduct. SuperSignal West Dura Extended Duration Substrate (Thermo-Scientific, USA) labeled and ImageQuant LAS 4000 system (Cytiva, Tokyo) analysis.

(8)免疫電顕
Nunc4wellプレートにカバーガラスをのせ、コラーゲンIVコーティングを施行。その上に誘導したヒト脂肪組織由来幹細胞、ヒト脂肪組織由来幹細胞、メラノーマ細胞を60~70%程度になるまで培養した。
0.1 M phosphate buffer (pH7.2) で緩衝された4%パラホルムアルデヒドで固定し、4℃で一晩置く。PBSで3回洗浄し0.15% glycine in PBSにつけ、0.1MPBに入りの12%ゼラチンに包埋した。ペレットを氷上で1mm以内に切り、2.3Mスクロース入りの0.1MPBに4℃で一晩浸し、specimen holder (Leica Microsystems, Vienna, Austria)に配置し、使用するまで液体窒素で保存する。
Leica UC7/FC7で-80℃で400nmの厚さに切り、2% methylcelluloseと2.3M sucroseを1:1で配合したものにつけ、amino propyltriethoxy silane (Matsunami Glass, Kishiwada, Japan)でコーティングされたガラスに置く。
その後、切片にmouse anti-HMB45antibody (1:50, Abcam ab733, Cambridge, UK) を用いて一晩4℃で一次抗体反応を行う。Alexa 488 conjugated donkey anti-mouse IgG (1:200, Invitrogen Life Technologies, Carlsbad, CA)を用いて一時間常温で二次抗体反応を行う。DAPIによる核染色後に蒸留水で希釈した50%グリセロールで封入し、BZ-X700 microscope (Keyence, Osaka, Japan)で観察した。
免疫電子顕微鏡についてはLeica UC7/FC7により-120℃で70nmまでの厚さの超薄型凍結切片を作成。2%メチルセルロースと2.3Mスクロースを1:1に配合した液に入れnickel gridに移動した。切片は0.15%のグリシンを含むPBSですすぎ、1%BSA入りのPBSで洗浄後、mouse anti-HMB45antibody (1:5, Abcam ab733, Cambridge, UK)を用いて一晩4℃で一次抗体反応を行う。
donkey anti-mouse IgG conjugated with 12 nm colloidal gold particles (1:40, The Jackson Laboratory, Bar Harbor, ME)を用いて二次抗体反応を行った。切片は1%GA入りのPBSで洗浄し、0.4%uranyl acetate (pH 4.0)を用いて1.8%methylcelluloseの薄い層に封入し、乾燥後にHitachi HT7700 electron microscope (Hitachi, Tokyo, Japan)で観察した。
(8) Immunoelectron microscopy A cover glass was placed on the Nunc4well plate and collagen IV coating was applied. The induced human adipose tissue-derived stem cells, human adipose tissue-derived stem cells, and melanoma cells were cultured to about 60 to 70%.
Immobilize with 4% paraformaldehyde buffered with 0.1 M phosphate buffer (pH 7.2) and set at 4 ° C. overnight. The cells were washed 3 times with PBS, soaked in 0.15% glycine in PBS, and embedded in 12% gelatin in 0.1 MPB. The pellet is cut into 1 mm 3 pieces on ice, soaked in 0.1 MPB containing 2.3 M sucrose overnight at 4 ° C., placed in a specimen holder (Leica Microsystems, Vienna, Austria) and stored in liquid nitrogen until use.
Cut to a thickness of 400 nm at -80 ° C with a Leica UC7 / FC7, dipped in a 1: 1 mixture of 2% methylcellulose and 2.3M cellulose, and coated with amino-polytriethoxy silane (Matsunami Glass, Kishiw) glass. Put in.
Then, the primary antibody reaction is carried out overnight at 4 ° C. using mouse anti-HMB45 antibody (1:50, Abcam ab733, Cambridge, UK) on the sections. A secondary antibody reaction is carried out at room temperature for 1 hour using Alexa 488 conjugated donkey anti-mouse IgG (1: 200, Invitrogen Life Technologies, Carlsbad, CA). After nuclear staining with DAPI, the cells were encapsulated in 50% glycerol diluted with distilled water and observed with a BZ-X700 microscope (Keyence, Osaka, Japan).
For the immunoelectron microscope, Leica UC7 / FC7 was used to prepare ultrathin frozen sections with a thickness of up to 70 nm at -120 ° C. 2% methylcellulose and 2.3M sucrose were placed in a 1: 1 mixture and transferred to nickel grid. Sections are rinsed with PBS containing 0.15% glycine, washed with PBS containing 1% BSA, and then primary antibody at 4 ° C. overnight using mouse anti-HMB45 antibody (1: 5, Abcam ab733, Cambridge, UK). Make a reaction.
A secondary antibody reaction was performed using donkey antibody-mouse IgG connected with 12 nm colloidal gold parts (1:40, The Jackson Laboratory, Bar Harbor, ME). Sections were washed with PBS containing 1% GA, encapsulated in a thin layer of 1.8% methylcellulose with 0.4% uranyl acetate (pH 4.0), dried and then Hitachi HT7700 erectron microscope (Hitachi, Tokyo, Tokyo, Tokyo, Tokyo, Japan). It was observed in Japan).

(9)3次元培養
コラーゲンゲル液としては、type1 collagen (3mg/mL)と 5-fold concentration of DMEとbuffer solutionを 7:2:1(purchased from Nitta Gelatin Corp, Osaka, Japan)の比率で混ぜたものを使用した。
NHDF(5.0x104~1.0x105cells/well)をコラーゲンゲル包埋したものをコラーゲンIVコートしたIWAKIの12well cell plate trans wellに750μL/wellずつ播種し、37℃で30分培養し上下に培地を入れる。2日後にNHEMまたは誘導したヒト脂肪組織由来幹細胞を2.5~5.0x10cells/wellでNHDFコラーゲンゲルの上に重ね、さらにその上にNHEMを5.0x104~1.0x10cells/wellで播種する。
15日培養後、4%PFAで固定し、パラフィン包埋を行う。脱パラフィンと賦活化後にnormal goat serum (1:200; from Vector Laboratories)でブロッキングを施行。
primary antibodies against HMB45 (1:25; from AbcamBiotechnology)とTYR (1:100; from Abcam, Biotechnology)を用いて一晩4℃で一次抗体反応を行う。
PBSで洗浄後、0.3%H/メタノールで内因性ペルオキシダーゼブロッキングを30分間施行。洗浄後、goat anti-mouse biotin IgG secondary antibody (1:300; from Molecular Probe)を用いて常温1時間二次抗体反応を行う。標識試薬としてAvidin (1:300;from DAKO)を用いて60分反応を行う。
その後DAB(PBS50mL+DAB500μL+H 10μL)で5分間発色を行い、1分間ヘマトキシリンで核染色を行う。洗浄し、脱水、透徹、封入を行い顕微鏡で観察する。
(9) Three-dimensional culture As a collagen gel solution, type1 collagen (3 mg / mL), 5-fold concentration of DME and buffer solution are mixed at a ratio of 7: 2: 1 (purchased from Nitta Gelatin Corp, Osaka), Osaka, Osaka. I used the one.
NHDF (5.0x104-1.0x105cells / well) embedded in collagen gel was seeded in IWAKI's 12-well cell plate transans well coated with collagen IV at a rate of 750 μL / well, cultured at 37 ° C for 30 minutes, and medium was cultivated above and below. put in. Two days later, NHEM or induced human adipose tissue-derived stem cells were overlaid on the NHDF collagen gel at 2.5-5.0x10 4 cells / well, and NHEM was further overlaid on it at 5.0x104-1.0x10 5 cells / well. Sow in.
After culturing for 15 days, the cells are fixed with 4% PFA and embedded in paraffin. After deparaffinization and activation, blocking was performed with normal goat serum (1: 200; from Vector Laboratories).
The primary antibody reaction is carried out at 4 ° C. overnight using primary antibodies against HMB45 (1:25; from Abcam Biotechnology) and TYR (1: 100; from Abcam, Biotechnology).
After washing with PBS, endogenous peroxidase blocking was performed with 0.3% H2O2 / methanol for 30 minutes. After washing, a secondary antibody reaction is carried out at room temperature for 1 hour using a goat anti-mouse biotin IgG secondary antibody (1: 300; from Molecular Probe). The reaction is carried out for 60 minutes using Avidin (1: 300; from DAKO) as a labeling reagent.
Then, color is developed with DAB (PBS 50 mL + DAB 500 μL + H 2 O 2 10 μL) for 5 minutes, and nuclear staining is performed with hematoxylin for 1 minute. Wash, dehydrate, permeate, enclose and observe under a microscope.

[結果]
(1)(脂肪組織幹細胞中にメラノサイト前駆細胞が存在すること)
a)免疫染色の結果、メラノサイトのマーカータンパクである、Melan A、MATP、HMB45、LAMP1、MITF、TYR、MelEM、Mel2が分化誘導前の脂肪組織幹細胞(ADSc)で発現されており、またメラノサイト系培養液で培養した本細胞(induced Me)でその発現は増強する(図1)。そしてそれは、特にメラノサイトのマスター遺伝子といわれるMITFにおいて顕著である(図2)。
[result]
(1) (Presence of melanocyte progenitor cells in adipose tissue stem cells)
a) As a result of immunostaining, melanocyte marker proteins, Melan A, MATP, HMB45, LAMP1, MITF, TYR, MelEM, and Mel2, are expressed in adipose tissue stem cells (ADSc) before induction of differentiation, and are melanocyte-based. Its expression is enhanced in the main cells (induced Me) cultured in the culture medium (Fig. 1). And it is particularly remarkable in MITF, which is called the master gene of melanocytes (Fig. 2).

b)RT-PCRの結果、分化誘導前の脂肪組織幹細胞(22851)でMITF、KIT、PAX3のメラノサイトの転写因子が発現されており、メラノサイト系培養液で培養した本細胞(induced Me)でその発現は増強する(図3-1及び図3-2)。 b) As a result of RT-PCR, transcription factors of melanocytes of MITF, KIT, and PAX3 were expressed in adipose tissue stem cells (22851) before induction of differentiation, and the transcription factors of melanocytes cultured in a melanocyte culture medium (induced Me) were expressed. Expression is enhanced (FIGS. 3-1 and 3-2).

c) siRNA法で脂肪組織幹細胞(22851 cell)のHMB45(前駆メラノソームタンパク)をノックダウンすると、本細胞におけるHMB45の発現が消退する(図4)。 c) When HMB45 (precursor melanosome protein) of adipose tissue stem cells (22851 cell) is knocked down by the siRNA method, the expression of HMB45 in the cells is eliminated (FIG. 4).

d)westernblottingにおいても、分化誘導前の脂肪組織幹細胞(22851)でHMB45とMITFが発現されており(図5)、メラノサイト系培養液で培養した本細胞(induced cells)でその発現は増強する(図6)。 d) HMB45 and MITF are also expressed in adipose tissue stem cells (22851) before induction of differentiation in western blinking (Fig. 5), and their expression is enhanced in main cells (induced cells) cultured in a melanocyte culture medium (FIG. 5). FIG. 6).

e)免疫電顕でも、分化誘導前の脂肪組織幹細胞(ASC)でHMB45が発現されており、メラノサイト系培養液で培養した本細胞(stimulated ASC)でその発現は増強することが観察される(図7)。 e) HMB45 is also expressed in adipose tissue stem cells (ASC) before induction of differentiation by immunoelectron microscopy, and it is observed that the expression is enhanced in the main cells (stimulated ASC) cultured in a melanocyte culture medium (stimulated ASC). FIG. 7).

(2)3次元培養において、脂肪細胞幹細胞中のメラノサイト前駆細胞が成熟メラノサイトの分化誘導されたこと
正常ヒトケラチノサイト(NHEK)と正常表皮メラノサイト(NHEM)、あるいはNHEKとメラノサイト系培養液で培養した脂肪組織幹細胞(induced cells)を、線維芽細胞を包埋したコラーゲンゲル上で3次元培養し表皮モデルを作成すると、その表皮基底層で、両培養系においてチロシナーゼ(TYR)とHMB45を発現する細胞がみられ、正常表皮構造に類似した色素細胞分布が再現された(図8)。
(2) In three-dimensional culture, melanocyte precursor cells in fat cell stem cells were induced to differentiate into mature melanocytes. Fat cultured in normal human keratinocytes (NHEK) and normal epidermal melanocytes (NHEM), or NHEK and melanocyte culture medium. When tissue stem cells (induced cells) were three-dimensionally cultured on a collagen gel in which fibroblasts were embedded to create an epidermal model, cells expressing tyrosinase (TYR) and HMB45 in both culture systems were found in the epidermal basal layer. It was observed, and the pigment cell distribution similar to the normal epidermal structure was reproduced (Fig. 8).

Claims (3)

ヒトメラノサイト前駆細胞を含有するヒト脂肪組織幹細胞を、ヒト線維芽細胞及びヒトケラチノサイトと共に培養することを特徴とする、ヒト成熟メラノサイト、ヒトケラチノサイト及びヒト線維芽細胞を含有する再生ヒト皮膚組織の製造法。 A method for producing regenerated human skin tissue containing human mature melanocytes, human keratinocytes and human fibroblasts, which comprises culturing human adipose tissue stem cells containing human melanosite progenitor cells together with human fibroblasts and human keratinocytes. .. ヒトメラノサイト前駆細胞を含有するヒト脂肪組織幹細胞が、ヒトメラノサイト前駆細胞を含有するヒト脂肪組織幹細胞、又はヒトメラノサイト前駆細胞を含有するヒト脂肪組織幹細胞をメラノサイト特異的培地で培養した細胞である請求項1記載の再生ヒト皮膚組織の製造法。 Claimed that the human adipose tissue stem cell containing human melanosite progenitor cell is a human adipose tissue stem cell containing human melanosite progenitor cell or a cell obtained by culturing human adipose tissue stem cell containing human melanosite progenitor cell in a melanosite-specific medium. 1. The method for producing a regenerated human skin tissue according to 1. 前記ヒト線維芽細胞及びヒトケラチノサイトと共に行う培養系が、コラーゲンゲル中で、ヒト線維芽細胞、ヒトケラチノサイト及び前記ヒト脂肪組織幹細胞を培養する系である請求項1又は2記載の再生ヒト皮膚組織の製造法。 The regenerated human skin tissue according to claim 1 or 2, wherein the culture system performed together with the human fibroblasts and human keratinocytes is a system for culturing human fibroblasts, human keratinocytes and the human adipose tissue stem cells in a collagen gel. Manufacturing method.
JP2020122407A 2020-07-16 2020-07-16 Method for producing regenerated human skin tissue Pending JP2022018946A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2020122407A JP2022018946A (en) 2020-07-16 2020-07-16 Method for producing regenerated human skin tissue

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2020122407A JP2022018946A (en) 2020-07-16 2020-07-16 Method for producing regenerated human skin tissue

Publications (1)

Publication Number Publication Date
JP2022018946A true JP2022018946A (en) 2022-01-27

Family

ID=80203453

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020122407A Pending JP2022018946A (en) 2020-07-16 2020-07-16 Method for producing regenerated human skin tissue

Country Status (1)

Country Link
JP (1) JP2022018946A (en)

Similar Documents

Publication Publication Date Title
Liu et al. Exosomes derived from human umbilical cord mesenchymal stem cells accelerate cutaneous wound healing by enhancing angiogenesis through delivering angiopoietin-2
Goumans et al. TGF-β1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro
Liu et al. Derivation of functional smooth muscle cells from multipotent human hair follicle mesenchymal stem cells
Steingen et al. Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells
Schneider et al. Long-term survival and characterisation of human umbilical cord-derived mesenchymal stem cells on dermal equivalents
Jin et al. Conditioned medium derived from FGF-2-modified GMSCs enhances migration and angiogenesis of human umbilical vein endothelial cells
US9867854B2 (en) Therapeutic method using cardiac tissue-derived pluripotent stem cells
Yoo et al. Application of mesenchymal stem cells derived from bone marrow and umbilical cord in human hair multiplication
Huang et al. Paracrine action of mesenchymal stromal cells delivered by microspheres contributes to cutaneous wound healing and prevents scar formation in mice
Strassburg et al. Human adipose-derived stem cells enhance the angiogenic potential of endothelial progenitor cells, but not of human umbilical vein endothelial cells
Yang et al. Epidermal stem cells (ESCs) accelerate diabetic wound healing via the Notch signalling pathway
Zhang et al. Effects of platelet-rich plasma on the activity of human menstrual blood-derived stromal cells in vitro
Lin et al. Characterisation of multipotent stem cells from human peripheral blood using an improved protocol
US8940294B2 (en) Methods of isolating and culturing stem cells
Zimoch et al. Bio-engineering a prevascularized human tri-layered skin substitute containing a hypodermis
US20180282690A1 (en) Method and culture medium for ex vivo culturing of epidermis-derived stem cells
Schiavo et al. Endothelial properties of third-trimester amniotic fluid stem cells cultured in hypoxia
Choi et al. Engineered extracellular microenvironment with a tunable mechanical property for controlling cell behavior and cardiomyogenic fate of cardiac stem cells
Yang et al. In vitro induction of human adipose-derived stem cells into lymphatic endothelial-like cells
Wang et al. Hair follicle stem cells isolated from newborn Yangtze River Delta White Goats
Yang et al. EGFL7-overexpressing epidermal stem cells promotes fibroblast proliferation and migration via mediating cell adhesion and strengthening cytoskeleton
JP2016516394A (en) Use of functional melanocytes easily differentiated from Muse cells, characteristic stem cells in human fibroblasts
AU2013287307A1 (en) Derivation and self-renewal of IsI1+ cells and uses thereof
Kim et al. A fibrin-supported myocardial organ culture for isolation of cardiac stem cells via the recapitulation of cardiac homeostasis
Cha et al. A method of isolation and culture of microvascular endothelial cells from mouse skin

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230616